Productivity costs of cardiovascular disease mortality across disease types and socioeconomic groups

Hannah Elizabeth Carter, Deborah Schofield, Rupendra Shrestha

    Research output: Contribution to journalArticleResearchpeer-review

    Abstract

    Background: Cardiovascular disease (CVD) is the single largest contributor to global mortality. Premature mortality due to CVD results in a loss of productivity, with associated economic and policy implications that are often overlooked.

    Methods: A human capital approach was adopted to project the long-term impacts of Australian CVD deaths in 2003 on labour force participation and the present value of lifetime income (PVLI) forgone. Impacts were modelled to the year 2030 and accounted for individual characteristics at the time of death including age, sex and socioeconomic status.

    Results: Premature deaths due to CVD in 2003 accounted for 51 659 working years and $2.69 billion in PVLI forgone when modelled to 2030 (95% CI $2.63 billion to $2.75 billion). The labour force impacts were highest for individuals aged between 35 and 64 at the time of death, and male deaths accounted for 87% of the total PVLI loss. The most costly disease type was ischaemic heart disease, followed by stroke and inflammatory heart disease. Deaths occurring in individuals residing in the most socioeconomically disadvantaged areas at the time of death had a disproportionately large impact on the total PVLI loss.

    Conclusions This study quantifies the relative productivity costs of CVD mortality across a range of disease types and socioeconomic groups. The magnitude of these costs highlights the scope for investments in effective healthcare interventions to provide positive economic returns and may assist decision makers in allocating resources among competing priorities.

    LanguageEnglish
    Article numbere000939
    Number of pages8
    JournalOpen Heart
    Volume6
    Issue number1
    DOIs
    Publication statusPublished - 1 Feb 2019

    Fingerprint

    Cost of Illness
    Cardiovascular Diseases
    Mortality
    Premature Mortality
    Economics
    Vulnerable Populations
    Social Class
    Myocardial Ischemia
    Heart Diseases
    Stroke
    Delivery of Health Care
    Costs and Cost Analysis

    Bibliographical note

    Copyright Author(s) (or their employer(s)) 2019. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

    Keywords

    • heart failure
    • hypertensive heart disease
    • myocardial ischaemia and infarction (IHD)
    • peripheral vascular disease
    • public health

    Cite this

    @article{2a7107f7f22e44e78ede8fa7ae5232d7,
    title = "Productivity costs of cardiovascular disease mortality across disease types and socioeconomic groups",
    abstract = "Background: Cardiovascular disease (CVD) is the single largest contributor to global mortality. Premature mortality due to CVD results in a loss of productivity, with associated economic and policy implications that are often overlooked.Methods: A human capital approach was adopted to project the long-term impacts of Australian CVD deaths in 2003 on labour force participation and the present value of lifetime income (PVLI) forgone. Impacts were modelled to the year 2030 and accounted for individual characteristics at the time of death including age, sex and socioeconomic status.Results: Premature deaths due to CVD in 2003 accounted for 51 659 working years and $2.69 billion in PVLI forgone when modelled to 2030 (95{\%} CI $2.63 billion to $2.75 billion). The labour force impacts were highest for individuals aged between 35 and 64 at the time of death, and male deaths accounted for 87{\%} of the total PVLI loss. The most costly disease type was ischaemic heart disease, followed by stroke and inflammatory heart disease. Deaths occurring in individuals residing in the most socioeconomically disadvantaged areas at the time of death had a disproportionately large impact on the total PVLI loss.Conclusions This study quantifies the relative productivity costs of CVD mortality across a range of disease types and socioeconomic groups. The magnitude of these costs highlights the scope for investments in effective healthcare interventions to provide positive economic returns and may assist decision makers in allocating resources among competing priorities.",
    keywords = "heart failure, hypertensive heart disease, myocardial ischaemia and infarction (IHD), peripheral vascular disease, public health",
    author = "Carter, {Hannah Elizabeth} and Deborah Schofield and Rupendra Shrestha",
    note = "Copyright Author(s) (or their employer(s)) 2019. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.",
    year = "2019",
    month = "2",
    day = "1",
    doi = "10.1136/openhrt-2018-000939",
    language = "English",
    volume = "6",
    journal = "Open Heart",
    issn = "2053-3624",
    publisher = "BMJ Publishing Group",
    number = "1",

    }

    Productivity costs of cardiovascular disease mortality across disease types and socioeconomic groups. / Carter, Hannah Elizabeth; Schofield, Deborah; Shrestha, Rupendra.

    In: Open Heart, Vol. 6, No. 1, e000939, 01.02.2019.

    Research output: Contribution to journalArticleResearchpeer-review

    TY - JOUR

    T1 - Productivity costs of cardiovascular disease mortality across disease types and socioeconomic groups

    AU - Carter, Hannah Elizabeth

    AU - Schofield, Deborah

    AU - Shrestha, Rupendra

    N1 - Copyright Author(s) (or their employer(s)) 2019. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

    PY - 2019/2/1

    Y1 - 2019/2/1

    N2 - Background: Cardiovascular disease (CVD) is the single largest contributor to global mortality. Premature mortality due to CVD results in a loss of productivity, with associated economic and policy implications that are often overlooked.Methods: A human capital approach was adopted to project the long-term impacts of Australian CVD deaths in 2003 on labour force participation and the present value of lifetime income (PVLI) forgone. Impacts were modelled to the year 2030 and accounted for individual characteristics at the time of death including age, sex and socioeconomic status.Results: Premature deaths due to CVD in 2003 accounted for 51 659 working years and $2.69 billion in PVLI forgone when modelled to 2030 (95% CI $2.63 billion to $2.75 billion). The labour force impacts were highest for individuals aged between 35 and 64 at the time of death, and male deaths accounted for 87% of the total PVLI loss. The most costly disease type was ischaemic heart disease, followed by stroke and inflammatory heart disease. Deaths occurring in individuals residing in the most socioeconomically disadvantaged areas at the time of death had a disproportionately large impact on the total PVLI loss.Conclusions This study quantifies the relative productivity costs of CVD mortality across a range of disease types and socioeconomic groups. The magnitude of these costs highlights the scope for investments in effective healthcare interventions to provide positive economic returns and may assist decision makers in allocating resources among competing priorities.

    AB - Background: Cardiovascular disease (CVD) is the single largest contributor to global mortality. Premature mortality due to CVD results in a loss of productivity, with associated economic and policy implications that are often overlooked.Methods: A human capital approach was adopted to project the long-term impacts of Australian CVD deaths in 2003 on labour force participation and the present value of lifetime income (PVLI) forgone. Impacts were modelled to the year 2030 and accounted for individual characteristics at the time of death including age, sex and socioeconomic status.Results: Premature deaths due to CVD in 2003 accounted for 51 659 working years and $2.69 billion in PVLI forgone when modelled to 2030 (95% CI $2.63 billion to $2.75 billion). The labour force impacts were highest for individuals aged between 35 and 64 at the time of death, and male deaths accounted for 87% of the total PVLI loss. The most costly disease type was ischaemic heart disease, followed by stroke and inflammatory heart disease. Deaths occurring in individuals residing in the most socioeconomically disadvantaged areas at the time of death had a disproportionately large impact on the total PVLI loss.Conclusions This study quantifies the relative productivity costs of CVD mortality across a range of disease types and socioeconomic groups. The magnitude of these costs highlights the scope for investments in effective healthcare interventions to provide positive economic returns and may assist decision makers in allocating resources among competing priorities.

    KW - heart failure

    KW - hypertensive heart disease

    KW - myocardial ischaemia and infarction (IHD)

    KW - peripheral vascular disease

    KW - public health

    UR - http://www.scopus.com/inward/record.url?scp=85062004478&partnerID=8YFLogxK

    UR - http://purl.org/au-research/grants/arc/LP100100158

    U2 - 10.1136/openhrt-2018-000939

    DO - 10.1136/openhrt-2018-000939

    M3 - Article

    VL - 6

    JO - Open Heart

    T2 - Open Heart

    JF - Open Heart

    SN - 2053-3624

    IS - 1

    M1 - e000939

    ER -